•Conduct high-throughput immune-related adverse events (irAEs) myocarditis antigen screening •Design and develop high-throughput in vitro screening assay to identify new cancer antigens from clinical samples•Extensive hands-on experience with molecular biology techniques including molecular cloning, PCR, lentiviral transduction, ELISA, whole plasmid sequencing

•Translation and Writing of [Janssen (Johnson & Johnson)] Imbruvica® (ibrutinib) Heritage Symposium Recap Meeting Summary

•Liaison between internal stakeholders and US food and drug administration (FDA) representatives for efficient endovascular intervention medical devices development strategies •Preparation and submission of FDA documents including a request for designation (RFD), FDA 510k / premarket approval (PMA) for class II/ III endovascular medical devices•Train and lead fellow and junior staff to study drug delivery methods for efficient T cell-based in vivo cancer immunotherapy

• Research therapeutic potential of ligand presentation anisotropy in pre-clinical CD8+ T cell-based adoptive cell therapy and its tumor reactivity • Write /revise/ proofreading/ review/ publish research articles in peer-reviewed international journals and presentation of research findings at both national and international conferences• Establish primary CD8+, CD3+/ Jurkat T cell in vitro/ ex vivo/ co-culture systems to study pre-clinical research projects developing innovative cancer immunotherapeutic strategy

• Ensure cGMP, cGDP, and regulatory compliance for pharmaceutical products • Prepare and review of Site Master File, Quality Manual, Standard Operating Procedures (SOPs), Specification and Qualification reports• Participate and perform internal audits and follow-ups on external audits